BioNTech, which worked with Pfizer to build an mRNA Covid vaccine, has partnered with the U.K. to turn the technology towards cancer and plans to treat 10,000 people by 2030.
Cancer Vaccine Trials—Using Same mRNA Tech Behind Covid Shots—Could Launch In U.K. This September
